Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04568629
Other study ID # 17031/001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 15, 2020
Est. completion date April 13, 2021

Study information

Verified date September 2021
Source University College, London
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study investigates how clinicians form intuitive judgements about the prognoses of palliative care patients after receiving advice perceived as coming from either a team member or an algorithm.


Description:

Using the Judge-Advisor System, the investigators will recruit clinicians working in palliative care for adults. Participants will be asked to complete an online survey and review five patient summaries ("vignettes") based on real cases derived from a previous study. Clinicians will be presented with key prognostic information and will be asked to provide an estimate of the probability that the patient will survive for two weeks (0-100%). After providing this initial estimate, participants will receive prognostic advice. While in reality all participants will receive the same advice, participants will be randomised into two groups and these groups will be informed that the advice is either: (1) provided by an algorithm; or (2) provided by a team colleague. Participants will then be given the opportunity to give a second, possibly revised estimate in the light of the advice received.


Recruitment information / eligibility

Status Completed
Enrollment 323
Est. completion date April 13, 2021
Est. primary completion date April 13, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Clinicians working in an adult palliative care service - Willing and able to provide written informed consent Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Advice from the PiPS-B14 prognostic tool
Participants were informed that prognostic advice came from the PiPS-B14 prognostic tool. PiPS-B14 is a validated prognostic algorithm that has been shown to be as accurate as an agreed multi-professional survival estimate. Participants were further informed that in a previous study the PiPS-B14 risk categories for predicting two-week survival were as accurate as a doctor's or a nurse's prediction.
Advice from another clinician
Participants were informed that prognostic advice came from another clinician. Doctors were told that advice was from a nurse, whereas nurses or other types of HCPs were told that advice was from a doctor.

Locations

Country Name City State
United Kingdom University College London London

Sponsors (1)

Lead Sponsor Collaborator
University College, London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Probability of survival estimate Clinicians' estimates of the probability of a patient surviving for two weeks (0-100%) Participants will have up to 7 months (until the study closes) to provide an estimate for each vignette
Secondary Participants' weighting policies (characteristics of the participants) Participants' responses to demographic questions Participants will have up to 7 months (until the study closes) to provide an estimate for each vignette
Secondary Participants' weighting policies (the advice itself) Strength of the prognostic advice provided by the advisor (0-100%) Participants will have up to 7 months (until the study closes) to provide an estimate for each vignette
See also
  Status Clinical Trial Phase
Completed NCT04078815 - End-of-life Practices in 2019 vs. 2014
Recruiting NCT04750395 - Comparing Haloperidol and Olanzapine in Treating Terminal Delirium Phase 2
Recruiting NCT06108375 - Differences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof N/A
Completed NCT04030910 - 'LIFEView' Audiovisual Technology: Virtual Travel to Support Wellbeing and Quality of Life at the End of Life N/A
Completed NCT03520270 - Prevalence of Potentially Inappropriate Treatments
Enrolling by invitation NCT05625854 - Using a Fan With Aromatherapy in Breathlessness Patients in Terminal Illness N/A
Recruiting NCT04257227 - Transcranial Magnetic Stimulation for Psychological Distress in Patients With Advanced Illness N/A
Completed NCT04678310 - iLIVE Volunteer Study
Completed NCT04456647 - Parenteral Nutrition Therapy in Patients With Incurable Cancer
Completed NCT02362295 - Prospective National Survey of the Palliative Situation Among Inmates in French Prisons N/A
Terminated NCT03886753 - Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
Active, not recruiting NCT04950608 - Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care Phase 2
Completed NCT03336489 - Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks
Completed NCT03392857 - End Of Life in the Critically Ill patiEnt
Completed NCT03697213 - The Surprise Study
Completed NCT01367613 - Open-Label Treatment Extension of Protocol MNTX 302 Phase 3
Recruiting NCT04612738 - Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations N/A
Completed NCT02067572 - A Randomized Controlled Trial Evaluating the Effectiveness of a Salvia-based Mouthwash in Palliative Care N/A
Withdrawn NCT03041571 - Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
Terminated NCT03616639 - Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function Phase 4